Contact
searchSearch
HMP Global

Conference Coverage

News
Comparing Onset of Action of Therapies in Rheumatoid Arthritis
11/13/2024
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to...
11/13/2024
Rheumatology & Arthritis
Conference Coverage
Treat-to-Target Tapering of TNFi Studied for Noninferiority in PsA, axSpA
01/03/2024
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic...
01/03/2024
Rheumatology & Arthritis
Conference Coverage
Victoria Konzett, MD, on RA Flares Based on SDAI and CDAI
12/27/2023
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Dr Peter Taylor on Effectiveness of Upadacitinib in RA Pain Management
12/26/2023
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Gregory McDermott, MD: Predictors of RA-ILD and Subtypes
12/26/2023
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Breakthrough COVID-19 Infection Among RA Patients After Third Dose
12/26/2023
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
This or That? Rieke Alten, MD, Reviews Treatment Preferences for RA Patients
12/20/2023
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Rheumatoid Arthritis and Long COVID—A Double Whammy
12/20/2023
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Vibeke Strand, MD, on Results of the Phase 3 SELECT-EARLY Trial
12/12/2023
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial...
12/12/2023
Rheumatology & Arthritis
Conference Coverage
JAK Inhibitors for Psoriatic Arthritis? Results of the JAK-pot Study
12/05/2023
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been...
12/05/2023
Rheumatology & Arthritis

Popular Articles
Video
Tofacitinib as a Treatment for Ankylosing Spondylitis: Exploring the Potential
02/09/2021
In this video, Atul Deodhar, MD, provides an overview of results from a phase 3 study that assessed whether the oral JAK inhibitor tofacitinib could be a treatment option for adults with ankylosing spondylitis. He had presented on the topic...
In this video, Atul Deodhar, MD, provides an overview of results from a phase 3 study that assessed whether the oral JAK inhibitor tofacitinib could be a treatment option for adults with ankylosing spondylitis. He had presented on the topic...
In this video, Atul Deodhar, MD,...
02/09/2021
Autoimmune
News
Hand Decline Is Similar With RA, PsA, and Even Psoriasis
12/14/2020
How do rheumatoid arthritis, psoriatic arthritis, and psoriasis impact objective and subjective parameters of hand function?
How do rheumatoid arthritis, psoriatic arthritis, and psoriasis impact objective and subjective parameters of hand function?
How do rheumatoid arthritis,...
12/14/2020
Autoimmune
News
Is COVID-19 Risk Greater Among Patients With Autoimmune Diseases?
10/22/2020
New findings shed light on the prevalence and clinical outcomes of COVID-19 among patients with autoimmune diseases. Find out which autoimmune disease therapies were deemed safe to use during the pandemic.
New findings shed light on the prevalence and clinical outcomes of COVID-19 among patients with autoimmune diseases. Find out which autoimmune disease therapies were deemed safe to use during the pandemic.
New findings shed light on the...
10/22/2020
Autoimmune
News
Can Prognostic Nutritional Index Predict Behçet Disease Activity?
09/08/2020
In an effort to identify a monitoring tool that measures disease activity, researchers evaluated the association between prognostic nutritional index and disease activity among patients with Behçet disease.
In an effort to identify a monitoring tool that measures disease activity, researchers evaluated the association between prognostic nutritional index and disease activity among patients with Behçet disease.
In an effort to identify a...
09/08/2020
Autoimmune
Poll
Poll: The Oral-Gut Connection
07/23/2020
Research indicates that there is a connection between oral health and inflammatory bowel disease. Do you address this issue with your patients? Take our quick poll to share your opinion!
Research indicates that there is a connection between oral health and inflammatory bowel disease. Do you address this issue with your patients? Take our quick poll to share your opinion!
Research indicates that there is...
07/23/2020
Autoimmune

Stay In the Know

Autoimmune Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use